Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter

被引:44
作者
Kramer, W [1 ]
Glombik, H [1 ]
Petry, S [1 ]
Heuer, H [1 ]
Schäfer, HL [1 ]
Wendler, W [1 ]
Corsiero, D [1 ]
Girbig, F [1 ]
Weyland, C [1 ]
机构
[1] Aventis Pharma Deutschland GMBH, Dis Grp Metab Dis, D-65926 Frankfurt, Germany
关键词
intestinal cholesterol absorption; cholesterol transporter; 2-azetidinone; transport protein; cholesterol transport inhibitor; photoaffinity labeling; small intestine;
D O I
10.1016/S0014-5793(00)02372-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To identify protein components of the intestinal cholesterol transporter, rabbit small intestinal brush border membrane vesicles were submitted to photoaffinity labeling using photoreactive derivatives of 2-azetidinone cholesterol absorption inhibitors. An integral membrane protein of M-r 145.3 +/- 7.5 kDa was specifically labeled in brush border membrane vesicles from rabbit jejunum and ileum. Its labeling was concentration-dependently inhibited by the presence of cholesterol absorption inhibitors whereas bile acids, D-glucose, fatty acids or cephalexin had no effect. The inhibitory potency of 2-azetidinones to inhibit photolabeling of the 145 kDa protein correlated with their in vivo activity to inhibit intestinal cholesterol absorption. These results suggest that an integral membrane protein of M-r, 145 kDa is (a component of) the cholesterol absorption system in the brush border membrane of small intestinal enterocytes. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 33 条
[1]  
BERGMAN M, 1995, 12 INT S DRUGS AFF L
[2]   2-AZETIDINONES AS INHIBITORS OF CHOLESTEROL ABSORPTION [J].
BURNETT, DA ;
CAPLEN, MA ;
DAVIS, HR ;
BURRIER, RE ;
CLADER, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) :1733-1736
[3]   OBSERVATIONS CONCERNING THE PRODUCTION AND EXCRETION OF CHOLESTEROL IN MAMMALS .11. THE INTESTINAL SITE OF ABSORPTION AND EXCRETION OF CHOLESTEROL [J].
BYERS, SO ;
FRIEDMAN, M ;
GUNNING, B .
AMERICAN JOURNAL OF PHYSIOLOGY, 1953, 175 (03) :375-379
[4]   2-azetidinone cholesterol absorption inhibitors: Structure-activity relationships on the heterocyclic nucleus [J].
Clader, JW ;
Burnett, DA ;
Caplen, MA ;
Domalski, MS ;
Dugar, S ;
Vaccaro, W ;
Sher, R ;
Browne, ME ;
Zhao, HR ;
Burrier, RE ;
Salisbury, B ;
Davis, HR .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) :3684-3693
[5]  
DAVIS HR, 1994, ATHEROSCLEROSIS, V109, P162
[6]   A target for cholesterol absorption inhibitors in the enterocyte brush border membrane [J].
Detmers, PA ;
Patel, S ;
Hernandez, M ;
Montenegro, J ;
Lisnock, J ;
Pikounis, B ;
Steiner, M ;
Kim, D ;
Sparrow, C ;
Chao, YS ;
Wright, SD .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (2-3) :243-252
[7]  
DIETSCHY JM, 1993, J LIPID RES, V34, P1637
[8]   CHOLESTEROL ABSORPTION BY JEJUNUM AND ILEUM [J].
FELDMAN, EB ;
HENDERSON, DH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1969, 193 (01) :221-+
[9]   ABSORPTION AND METABOLISM OF DIETARY-CHOLESTEROL [J].
GRUNDY, SM .
ANNUAL REVIEW OF NUTRITION, 1983, 3 :71-96
[10]   Inhibition of cholesterol absorption with CP-148,623 lowers serum cholesterol in humans [J].
Harris, WS ;
Windsor, SL ;
Newton, FA ;
Gelfand, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (03) :385-389